Anika Therapeutics
This article was originally published in The Gray Sheet
Executive Summary
Anika Therapeutics: Premarket approval application for the firm's Orthovisc intra-articular injectable hyaluronic acid treatment for osteoarthritis of the knee has been accepted for filing by FDA following submission in December, the firm states ("The Gray Sheet" Jan. 5, In Brief). The notification states that FDA does not plan to refer the PMA for advisory panel review, Anika reports...